Tag: fraud

PHILADELPHIA, June 26, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Trevi Therapeutics, Inc. (NASDAQ: TRVI) (“Trevi”) on behalf of the company’s long-term investors. 

According to Precedence Research, the global carbon credit market size is valued at USD 933.23 billion in 2025 and is expected to be worth USD 16,379.53 billion by 2034, growing at a robust CAGR of 37.68% from 2025 to 2034.

WARSAW, Poland, June 26, 2025 (GLOBE NEWSWIRE) -- BNPL payments are no longer just a way of financing purchases, but also constitute an innovative factor supporting the development of the Polish credit market. An analysis carried out by the Polish credit bureau BIK found that BNPL users are good at repaying their debts. For 40 percent of “thin-file bank customers” who also use BNPL, combining the two data sources may improve their creditworthiness. The degree of such an improvement can have a significant impact on credit decisions. It is also worth noting that this analysis was made possible by the unique data gathered by BIK and by the reporting standards for BNPL transactions developed together with the financial sector.

SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers and certain of Hims & Hers’ top executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint is captioned Yaghsizian v. Hims & Hers Health, Inc., No. 25-cv-05321 (N.D. Cal.).

SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025. Mr. Bellemin, who assumed the CFO role in November 2020, is reportedly departing to pursue other endeavors, according to a regulatory filing. Bellemin’s exit comes at a tumultuous time, as the company is grappling with a recent commercial setback for its flagship drug, Amtagvi, and the specter of a class-action securities lawsuit.

SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025.

PHILADELPHIA, June 25, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) on behalf of purchasers of Civitas securities between February 27, 2024 through February 24, 2025, inclusive (the “Class Period”).

ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cable One, Inc. (“Cable One” or the “Company”) (NYSE: CABO) complied with federal securities laws. On May 1, 2025, Cable One reported first quarter 2025 results, revealing, among other things, a decline in residential data revenues “due primarily to a decrease in residential data subscribers and a decrease in average revenue per unit (“ARPU”) as a result of the implementation of targeted pricing and product offerings in certain markets.” Following this news, the price of the Company’s stock dropped. 

Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services